Institutional
Tetragon Partners GP Ltd
CIK 0001515070
$515.1M
Reported AUM
34
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · Tetragon Partners GP Ltd · Q1 2026
AI · grounded in 13F
Tetragon Partners GP Ltd established a new position in WBD valued at $25.37M. The fund also opened new stakes in DFTX for $3.8M and SLNO for $3.42M. To fund these moves, the firm closed positions in RAPT and AM6, reducing its holdings by $4.46M and $3.71M respectively.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Ticker | Issuer | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|
| 1 | PATH | UIPATH INC | $279.8M | 54.32% | +7,757,628 | +44.5% |
| 2 | KGEI | KOLIBRI GLOBAL ENERGY INC | $37.5M | 7.28% | -100,000 | -1.4% |
| 3 | WBD | WARNER BROS DISCOVERY INC | $25.4M | 4.92% | +923,725 | NEW |
| 4 | WK | WORKIVA INC | $14.9M | 2.89% | +100,000 | +66.7% |
| 5 | LYFT | LYFT INC | $13.3M | 2.58% | — | HELD |
| 6 | CXM | SPRINKLR INC | $13.2M | 2.56% | — | HELD |
| 7 | AUTL | AUTOLUS THERAPEUTICS LTD | $13.1M | 2.55% | — | HELD |
| 8 | CLDX | CELLDEX THERAPEUTICS INC NEW | $9.9M | 1.92% | +68,516 | +28.1% |
| 9 | AXSM | AXSOME THERAPEUTICS INC. | $9.3M | 1.81% | +28,125 | +104.4% |
| 10 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $8.0M | 1.55% | +30,263 | +31.2% |
| 11 | NKTR | NEKTAR THERAPEUTICS | $7.4M | 1.44% | +33,750 | +48.7% |
| 12 | ANNX | ANNEXON INC | $7.2M | 1.39% | -740,000 | -36.4% |
| 13 | PHVS | PHARVARIS N V | $6.3M | 1.22% | +26,999 | +13.9% |
| 14 | ALKS | ALKERMES PLC | $5.7M | 1.10% | +18,619 | +13.2% |
| 15 | AGIO | AGIOS PHARMACEUTICALS INC | $5.6M | 1.08% | +2,821 | +1.7% |
| 16 | IMVT | IMMUNOVANT INC | $5.4M | 1.05% | +52,320 | +31.5% |
| 17 | PRAX | PRAXIS PRECISION MEDICINES I | $5.1M | 1.00% | -7,000 | -30.5% |
| 18 | KRYS | KRYSTAL BIOTECH INC | $5.1M | 0.99% | +7,854 | +66.5% |
| 19 | DYN | DYNE THERAPEUTICS INC | $4.7M | 0.91% | +10,135 | +4.1% |
| 20 | AMLX | AMYLYX PHARMACEUTICALS INC | $4.4M | 0.86% | +45,049 | +16.5% |
| 21 | MBX | MBX BIOSCIENCES INC | $4.3M | 0.84% | +2,153 | +1.5% |
| 22 | DFTX | DEFINIUM THERAPEUTICS INC | $3.8M | 0.73% | +199,994 | NEW |
| 23 | SLNO | SOLENO THERAPEUTICS INC | $3.4M | 0.66% | +102,125 | NEW |
| 24 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $3.3M | 0.65% | +36,516 | +44.1% |
| 25 | SLN | SILENCE THERAPEUTICS PLC | $3.3M | 0.64% | +264,792 | +72.5% |
| 26 | ACAD | ACADIA PHARMACEUTICALS INC | $3.2M | 0.62% | +144,620 | NEW |
| 27 | IONS | IONIS PHARMACEUTICALS INC | $3.1M | 0.61% | +41,764 | NEW |
| 28 | MPLT | MAPLIGHT THERAPEUTICS INC | $2.3M | 0.44% | -52,410 | -31.9% |
| 29 | RLAY | RELAY THERAPEUTICS INC | $1.8M | 0.35% | +181,543 | NEW |
| 30 | SNOW | SNOWFLAKE INC | $1.5M | 0.29% | — | HELD |
| 31 | AARD | AARDVARK THERAPEUTICS INC | $1.2M | 0.23% | +316,621 | NEW |
| 32 | TECX | TECTONIC THERAPEUTIC INC | $1.2M | 0.23% | +37,588 | NEW |
| 33 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $827K | 0.16% | +39,473 | NEW |
| 34 | KPTI | KARYOPHARM THERAPEUTICS INC | $574K | 0.11% | +102,984 | NEW |
| 35 | RAPT | RAPT THERAPEUTICS INC | — | — | -131,770 | EXITED |
| 36 | AM6 | AMICUS THERAPEUTICS INC | — | — | -260,771 | EXITED |
| 37 | ZVRA | ZEVRA THERAPEUTICS INC | — | — | -192,518 | EXITED |
| 38 | AVDL | AVADEL PHARMACEUTICALS PLC | — | — | -43,763 | EXITED |
Source: SEC EDGAR · accession 0000919574-26-003297. 13F discloses long positions only — shorts, foreign equities, and options are excluded.